April 30, 2020 / 1:50 AM / a month ago

BRIEF-Paradigm Biopharmaceuticals Says Completed Treatment Of Patients With Zilosul

April 30 (Reuters) - Paradigm Biopharmaceuticals Ltd :

* COMPLETED TREATMENT OF ALL 10 PATIENTS WITH ZILOSUL UNDER FDA IND EXPANDED ACCESS PROGRAM

* ADVISED BY FDA THAT CO’S ORPHAN DESIGNATION REQUEST FOR MPS- I GRANTED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below